ABON Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABON, and what generic and branded alternatives to ABON drugs are available?
ABON has three approved drugs.
Drugs and US Patents for ABON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abon Pharms Llc | ATOVAQUONE | atovaquone | SUSPENSION;ORAL | 214272-001 | Oct 25, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abon Pharms Llc | SUCRALFATE | sucralfate | SUSPENSION;ORAL | 216726-001 | Mar 21, 2024 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abon Pharms Llc | CLOFARABINE | clofarabine | SOLUTION;INTRAVENOUS | 204029-001 | May 9, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.